Myasthenia gravis: Myasthenia gravis (MG) is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles.
Filter registries Inpat., Oupat., Death, KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
G6_MYASTHENIA
Extra metadata
List of similar endpoints to
Myasthenia gravis
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 283 | 156 | 127 |
| Unadjusted prevalence (%) | 0.11 | 0.11 | 0.11 |
| Mean age at first event (years) | 51.60 | 45.63 | 58.93 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.04 | 2.76 [1.38, 5.51] | 3.9e-3 | 28 |
| 15 years | 0.02 | 3.10 [1.63, 5.89] | 5.4e-4 | 21 |
| 5 years | 0.01 | 6.77 [3.02, 15.16] | 3.4e-6 | 12 |
| 1 year | - | - | - | - |
Index endpoint: G6_MYASTHENIA – Myasthenia gravis
GWS hits: 0
before Myasthenia gravis
after Myasthenia gravis
Loading survival analyses plot
Loading survival analyses table